Amgen (AMGN) Other Working Capital Changes (2009 - 2026)

Amgen (AMGN) has reported Other Working Capital Changes for 18 consecutive years, with -$8.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 103.98% year-over-year to -$8.0 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 38.48% YoY), while the FY2025 annual figure was $1.3 billion, up 94.33% from the prior year.
• Other Working Capital Changes came in at -$8.0 million for Q1 2026 at Amgen, down from $577.0 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $577.0 million in Q4 2025, with the low at -$241.0 million in Q2 2022.
• Average Other Working Capital Changes over 5 years is $130.4 million, with a median of $139.0 million recorded in 2023.
• Across the five-year window, Other Working Capital Changes tumbled 315.18% in 2022 and soared 4021.43% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at -$92.0 million in 2022, then jumped by 352.17% to $232.0 million in 2023, then slumped by 93.97% to $14.0 million in 2024, then jumped by 4021.43% to $577.0 million in 2025, then tumbled by 101.39% to -$8.0 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$8.0 million, $577.0 million, and $283.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.